Lexington, MA, United States of America

Jean-Baptiste Telliez

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 11.7

ph-index = 2

Forward Citations = 57(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: **Jean-Baptiste Telliez: Innovator in Pharmaceutical Chemistry**

Introduction

Jean-Baptiste Telliez, a prominent inventor based in Lexington, MA, has made significant strides in the field of pharmaceutical chemistry with a total of 8 patents under his name. His innovative approaches focus on developing new compounds that contribute to the treatment of conditions such as alopecia. Telliez's work is characterized by a blend of creativity and scientific rigor, demonstrating a keen understanding of chemistry and its applications in healthcare.

Latest Patents

Among his latest patents, Telliez introduced novel pyrrolo compounds, specifically pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl, and pyrrolo[2,3-d]pyridinyl acrylamides. These compounds provide methods for treating alopecia by utilizing pharmaceutically active substances. His patents detail the specific structures and compositions of these compounds, which include various chemical modifications to enhance their effectiveness. Furthermore, he has developed aminopyrimidinyl compounds that serve as Janus Kinase inhibitors, showcasing their potential in therapeutic applications.

Career Highlights

Jean-Baptiste Telliez's career is marked by his association with Pfizer Corporation, a leading global pharmaceutical company renowned for its research and development in medications. His innovative contributions at Pfizer have positioned him as a key player in the search for new therapies, particularly in dermatology and related fields.

Collaborations

Throughout his tenure at Pfizer, Telliez has worked alongside notable colleagues, including John Isidro Trujillo and Andrew Fensome. Their collaborative efforts have propelled advancements in therapeutic development and fostered an environment of shared knowledge and innovation within the pharmaceutical sector.

Conclusion

In conclusion, Jean-Baptiste Telliez exemplifies the spirit of innovation in pharmaceutical research. With his impressive track record of patents and collaborations, his contributions play a vital role in the continuous evolution of treatment methodologies, particularly in conditions such as alopecia. As he continues to develop new solutions, Telliez remains a pivotal figure in the field of pharmaceutical inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…